Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
M. Rosinska
Observed name:
M. Rosińska
Institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
Observed institutions:
Oslo University Hospital,
The Maria Sklodowska-Curie National Research Institute of Oncology
ORCID:
0000-0002-6256-7809
Observed ORCID:
0000-0002-6256-7809
OpenAlex ID:
A5043150801
Impact of HIV-1 Subtype on CD4 Count at HIV Seroconversion, Rate of Decline, and Viral Load Set Point in European Seroconverter Cohorts
2012
·
G. Touloumi
, N. Pantazis
, et al.
·
Clinical Infectious Diseases
·
119
Accelerating real-world data collection using large language models in rare neoplasms: a bone sarcoma example
2026
·
P. Teterycz
, S. Rynkun
, et al.
·
ESMO Real World Data and Digital Oncology
·
1
PDF
148P Privacy-preserving pan-European oncology benchmarking in the DigiONE network using federated real-world data: The DigiACT s
2026
·
A. Traverso
, A. Dekker
, et al.
·
ESMO Real World Data and Digital Oncology
PDF
557eP Advanced thymic squamous cell carcinoma: Results of palliative systemic treatment in long-term follow-up
2026
·
M. Knetki-Wroblewska
, D.M. Kowalski
, et al.
·
ESMO Open
184P Comprehensive comparison of on-premise large language models (LLMs) for data abstraction in rare cancers from unorganized non-English medical documentation
2025
·
P. Teterycz
, S. Rynkun
, et al.
·
ESMO Real World Data and Digital Oncology
1662P A phase II, open label study to evaluate the safety and clinical activity of balstilimab in patients with advanced/metastatic non-melanoma skin cancers (AGENONMELA)
2025
·
I. Lugowska
, A. Dawidowska
, et al.
·
Annals of Oncology
160P Baseline IL-8 level as a predictive biomarker for anti-PD1 therapy in nonmelanoma skin cancers: Insights from a phase II agenonmela trial
2025
·
I. Lugowska
, A. Dawidowska
, et al.
·
ESMO Open
PDF
Response to Anti-PD-1 Therapy in a Muir-Torre Syndrome Patient with Advanced Sebaceous Carcinoma: A Preliminary Report
2025
·
M. Slowinska
, A. Dawidowska
, et al.
·
EJC Skin Cancer
67P Detrimental effect of the COVID-19 pandemic on patients with adult extremity bone sarcoma: Reference center experience
2023
·
P. Teterycz
, B. Szostakowski
, et al.
·
ESMO Open
Show more works
View as search
Works count:
9
Citation count:
120
H-index:
1
I10-index:
1
Year
Topic
Type